SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-22-035213
Filing Date
2022-06-08
Accepted
2022-06-08 19:11:08
Documents
1
Period of Report
2022-06-06

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 4102
  Complete submission text file 0001209191-22-035213.txt   5523
Mailing Address 111 OYSTER POINT BLVD. SOUTH SAN FRANCISCO CA 94080
Business Address 111 OYSTER POINT BLVD. SOUTH SAN FRANCISCO CA 94080 650-392-8412
SUTRO BIOPHARMA, INC. (Issuer) CIK: 0001382101 (see all company filings)

IRS No.: 452441988 | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 9640 MEDICAL CENTER DRIVE ROCKVILLE MD 20850
Business Address
Wigginton Jon Marc (Reporting) CIK: 0001587487 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38662 | Film No.: 221004596